USANA HEALTH SCIENCES INC

For the period ended Dec 30, 2023. Filed Feb 27, 2024.

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2023 · Filed Feb 27, 2024

USNA$13.85+1.6%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Contents

Signatures

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

USANA Health Sciences, Inc.
By:	/s/ Jim H. Brown
	Jim H. BrownChief Executive Officer and President

Date: February 27, 2024

Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.

Kevin G. Guest
Signature	Title	Date
/s/ Jim H. Brown	Chief Executive Officer and President	February 27, 2024
Jim H. Brown	(Principal Executive Officer)
/s/ G. Douglas Hekking	Chief Financial Officer	February 27, 2024
G. Douglas Hekking	(Principal Financial and Accounting Officer)
/s/ Kevin G. Guest	Executive Chairman of the Board	February 27, 2024
/s/ Gilbert A. Fuller	Director	February 27, 2024
Gilbert A. Fuller
/s/ John T. Fleming	Director	February 27, 2024
John T. Fleming
/s/ J. Scott Nixon	Director	February 27, 2024
J. Scott Nixon
/s/ Frederic J. Winssinger	Director	February 27, 2024
Frederic J. Winssinger
/s/ Xia Ding	Director	February 27, 2024
Xia Ding
/s/ Timothy E. Wood	Director	February 27, 2024
Timothy E. Wood
/s/ Peggie Pelosi	Director	February 27, 2024
Peggie Pelosi

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.